Evidence map›Paper›PMID 33262181›Full record

ArticleCancer discovery2020

A Sweet Approach to Heat Up Cancer Response to Immunotherapy.

Oliver M T Pearce, Heinz Läubli

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cancer discovery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Oliver M T PearceCentre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom. o.pearce@qmul.ac.uk.
Heinz LäubliDepartment of Biomedicine, University of Basel and Division of Oncology, University Hospital Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0002-8910-5620
Queen Mary University of London · GBUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Song and colleagues describe how N-glycans stabilize expression of checkpoint molecule B7-H4 that suppresses T-cell function. Inhibiting N-glycan stabilization of B7-H4 generates an immune hot cancer that is more responsive to combination therapies.

Indexed as

Breast NeoplasmsV-Set Domain-Containing T-Cell Activation Inhibitor 1GlycosylationHumansImmunotherapyT-LymphocytesV-Set Domain-Containing T-Cell Activation Inhibitor 1

Identifiers

PMID33262181
OpenAlexW3107299721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.